|
BIO Letter
Letter from nearly 160 CEOs and biotech leaders opposing prescription drug importation (June 7, 2004)
Read the letter (450 KB PDF)
BIO Comments
to the HHS Task Force regarding Drug Importation (163 KB PDF) (June 1, 2004)
BIO Testimony
Before The Senate Judiciary Committee (July 14, 2004)
Before The Senate Committee On Health, Education, Labor, & Pensions (May 20, 2004)
BIO Testimony to the HHS Importation Task Force (Apr. 14, 2004)
Fact Sheet
Rx Drug Importation Poses Immediate and Incalculable Risk to American Patients (Apr. 19, 2004)
53 Senators send letter opposed to HR 2427 (197 KB PDF; July 24, 2003)
BIO Board of Directors letter
to US House of Representatives opposing HR 2427 (July 21, 2003) (193 KB PDF).
Letter in Opposition of H.R. 2427, to House Speaker Dennis Hastert (July 15, 2003)
Analysis of H.R. 2427 (Rep. Gutknecht, "Pharmaceutical Market Access Act of 2003") (July 11, 2003)
Reimportation Legislation
| 
